A new versatile and compact lentiviral vector

Molecular Biotechnology

Volumn 29, Issue 1, 2005, Pages 47-55

  Johansen, Jens Leander ^a   Dagø, Lone ^b   Tornøe, Jens ^b   Rosenblad, Carl ^b   Kusk, Philip ^b  

^a H LUNDBECK A S   (Denmark)

^b NsGene AS   (Denmark)

Author keywords

In vivo gene delivery; Lentiviral vector; Transgene expression

Indexed keywords

CELLS; CLONING; GENES; RESEARCH LABORATORIES; VECTORS;

IN VIVO GENE DELIVERY; LENTIVIRAL VECTOR; POLYLINKERS; TRANSGENE EXPRESSION;

GENETIC ENGINEERING;

LENTIVIRUS VECTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; CORPUS STRIATUM; DNA MODIFICATION; EMBRYO; FEMALE; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; RAT; VIRAL GENE DELIVERY SYSTEM;

HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 26244451017     PISSN: 10736085     EISSN: None     Source Type: Journal    
DOI: 10.1385/MB:29:1:47     Document Type: Article

References (39)

1. Buchschacher, G. L. Jr. and Wong-Staal, F. (2000) Development of lentiviral vectors for gene therapy for human diseases. Blood 95, 2499-2504.
2. Zufferey, R., et al. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.
3. Kim, V. N., Mitrophanous, K., Kingsman, S. M., and Kingsman, A. J. (1998) Minimal requirement for a lentivirus vector based on human immunodeficiency virus type 1. J. Virol. 72, 811-816.
4. Dull, T., et al. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
5. Uchida, N., et al. (1998) HIV, but not murine leukemia virus, vectors mediate high efficiency gene transfer into freshly isolated G0/G1 human hematopoietic stem cells. Proc. Natl. Acad. Sci. USA 95, 11939-11944.
6. Naldini, L., et al. (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
7. Burns, J. C., et al. (1993) Vesicular stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to very high titer and efficient gene transfer into mammalian and nonmammalian cells. Proc. Natl. Acad. Sci. USA 90, 8033-8037.
8. Sirven, A., et al. (2001) Enhanced transgene expression in cord blood CD34(+)-derived hematopoietic cells, including developing T cells and NOD/SCID mouse repopulating cells, following transduction with modified trip lentiviral vectors. Mol. Ther. 3, 438-448.
9. Sirven, A., et al. (2000) The human immunodeficiency virus type-1 central DNA flap is a crucial determinant for lentiviral vector nuclear import and gene transduction of human hematopoietic stem cells. Blood 96, 4103-4110.
10. Yam, P. Y., et al. (2002) Design of HIV vectors for efficient gene delivery into human hematopoietic cells. Mol. Ther. 5, 479-484.
11. Bonci, D., et al. (2003) "Advanced" generation lentiviruses as efficient vectors for cardiomyocyte gene transduction in vitro and in vivo. Gene Ther. 10, 630-636.
12. Fleury, S., et al. (2003) Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo. Circulation 107, 2375-2382.
13. Park, F. and Kay, M. A. (2001) Modified HIV-1 based lentiviral vectors have an effect on viral transduction efficiency and gene expression in vitro and in vivo. Mol. Ther. 4, 164-173.
14. Zennou, V., et al. (2001) The HIV-1 DNA flap stimulates HIV vector-mediated cell transduction in the brain. Nat. Biotechnol. 19, 446-450.
15. Zufferey, R., Donello, J. E., Trono, D., and Hope, T. J. (1999) Woodchuck hepatitis virus posttranscriptional regulatory element enhances expression of transgenes delivered by retroviral vectors. J. Virol. 73, 2886-2892.
16. Deglon, N., et al. (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 11, 179-190.
17. Ramezani, A., Hawley, T. S., and Hawley, R. G. (2000) Lentiviral vectors for enhanced gene expression in human hematopoietic cells. Mol. Ther. 2, 458-469.
18. Lotti, F., et al. (2002) Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement. J. Virol. 76, 3996-4007.
19. Gossen, M., et al. (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268, 1766-1769.
20. Gossen, M. and Bujard, H. (1992) Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. USA 89, 5547-5551.
21. Kafri, T., van Praag, H., Gage, F. H., and Verma, I. M. (2000) Lentiviral vectors: regulated gene expression. Mol. Ther. 1, 516-521.
22. Reiser, J., Lai, Z., Zhang, X. Y., and Brady, R. O. (2000) Development of multigene and regulated lentivirus vectors. J. Virol. 74, 10589-10599.
23. Vigna, E., et al. (2002) Robust and efficient regulation of transgene expression in vivo by improved tetracycline-dependent lentiviral vectors. Mol. Ther. 5, 252-261.
24. Johansen, J., et al. (2002) Evaluation of Tet-on system to avoid transgene down-regulation in ex vivo gene transfer to the CNS. Gene Ther. 9, 1291-1301.
25. Koponen, J. K., et al. (2003) Doxycycline-regulated lentiviral vector system with a novel reverse transactivator rtTA2S-M2 shows a tight control of gene expression in vitro and in vivo. Gene Ther. 10, 459-466.
26. Zufferey, R., et al. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.
27. Miyoshi, H., et al. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150-8157.
28. VIR x SYS. Press releases. http://www.virxsys.com/news_and_events.html. 2003.
29. NWFSC Molecular Biology Forums. http://micro. nwfsc.noaa.gov/protocols/ methods/DNA-PCRMethodsDocs/10-2002/10.23.02.6333.html.
30. Tornoe, J., Kusk, P., Johansen, T. E., and Jensen, P. R. (2002) Generation of a synthetic mammalian promoter library by modification of sequence spacing transcription factor binding sites. Gene 297, 21-32.
31. Renfranz, P. J., Cunningham, M. G., and McKay, R. D. (1991) Region-specific differentiation of the hippocampal stem cell line HiB5 upon implantation into the developing mammalian brain. Cell 66, 713-729.
32. Naldini, L., et al. (1996) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. USA 93, 11382-11388.
33. Georgievska, B., et al. (2002) Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector. Neuroreport 13, 75-82.
34. Ratner, L., et al. (1985) Complete nucleotide sequence of the AIDS virus, HTLV-III. Nature 313, 277-284.
35. van den Pol, A. N. and Ghosh, P. K. (1998) Selective neuronal expression of green fluorescent protein with cytomegalovirus promoter reveals entire neuronal arbor in transgenic mice. J. Neurosci. 18, 10640-10651.
36. Blomer, U., et al. (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
37. Fritschy, J. M., et al. (1996) Brain cell type specificity and gliosis-induced activation of the human cytomegalovirus immediate-early promoter in transgenic mice. J. Neurosci. 16, 2275-2282.
38. Aiba-Masago, S., et al. (1999) Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice. Am. J. Pathol. 154, 735-743.
39. Jakobsson, J., et al. (2003) Targeted transgene expression in rat brain using lentiviral vectors. J. Neurosci. Res. 73, 876-885.